4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-046428
SVP & Chief Financial Officer sold 25,000 shares at $17.79 ($444,750)
- SVP & Chief Financial Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP & Chief Financial Officer | 2019-08-14 | Option exercise | +25,000 | $7.21 | $180,250 | 152,935 | D |
| Labrucherie Gil M SVP & Chief Financial Officer | 2019-08-14 | Sale | −25,000 | $17.79 | $444,750 | 127,935 | D |
| Derivatives | |||||||
| Labrucherie Gil M SVP & Chief Financial Officer | 2019-08-14 | Option exercise · Stock Option | −25,000 | 0 | D | ||
| Open-market sales · 25,000 sh · avg $17.79 · $444,750 | |||||||
Loading xslF345X03/doc4.xml…